CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 109 filers reported holding CYTOKINETICS INC in Q1 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,424,000 | +15.4% | 150,000 | -14.3% | 0.58% | +28.1% |
Q1 2016 | $1,234,000 | -66.3% | 175,000 | -50.0% | 0.45% | -62.5% |
Q4 2015 | $3,661,000 | +37.6% | 350,000 | +25.0% | 1.20% | -2.0% |
Q1 2014 | $2,660,000 | +172.8% | 280,000 | +86.7% | 1.23% | +121.2% |
Q4 2013 | $975,000 | – | 150,000 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |